| Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis (NCT03706209) | MetrioPharm AG | 2018-02-27 |
| Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study) (NCT03452397) | Oyster Point Pharma, Inc. | 2018-02-27 |
| Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant (NCT03380962) | Stanley Jordan, MD | 2018-02-27 |
| To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin (NCT03467412) | Follicum AB | 2018-02-27 |
| Fatigue Interventions in Cancer (Exercise Intervention) (NCT03421782) | University of Utah | 2018-02-26 |
| Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies (NCT03453619) | Apellis Pharmaceuticals, Inc. | 2018-02-26 |
| Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning (NCT03311503) | David Williams | 2018-02-26 |
| Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk (NCT03113994) | Dr. B. Catharine. Craven | 2018-02-26 |
| Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma (NCT03389438) | Beijing Huanxing Cancer Hospital | 2018-02-26 |
| Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer (NCT03460275) | Sun Yat-sen University | 2018-02-26 |
| An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression (NCT03222570) | University of Minnesota | 2018-02-26 |
| PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer . (NCT03275506) | ARCAGY/ GINECO GROUP | 2018-02-26 |
| Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (NCT03487276) | InflaRx GmbH | 2018-02-26 |
| Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma (NCT03370718) | M.D. Anderson Cancer Center | 2018-02-26 |
| A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva (NCT03188666) | Regeneron Pharmaceuticals | 2018-02-26 |
| CX-8998 for Absence Seizures (NCT03406702) | Jazz Pharmaceuticals | 2018-02-25 |
| Impact of Rutin and Vitamin C Combination on Oxidative Stress, Insulin Sensitivity and Lipid Profile in Type 2 Diabetic Patients (NCT03437902) | Ain Shams University | 2018-02-24 |
| The Role of Probiotics in Improving Quality of Life in Women With Functional Constipation (NCT03829358) | Fakultas Kedokteran Universitas Indonesia | 2018-02-24 |
| To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD (NCT03404466) | Zhejiang Huahai Pharmaceutical Co., Ltd. | 2018-02-24 |
| Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP) (NCT03405792) | University of Florida | 2018-02-23 |
| First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma (NCT03324282) | University Hospital, Bordeaux | 2018-02-23 |
| Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in the Preservation of the Tooth Socket (NCT03980847) | Islamic Azad University, Sanandaj | 2018-02-23 |
| Kadcyla In pAtients With bRAin Metastasis (NCT03203616) | Jules Bordet Institute | 2018-02-23 |
| A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL) (NCT04771507) | Jeanette Lundin | 2018-02-23 |
| DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01) (NCT03384940) | Daiichi Sankyo Co., Ltd. | 2018-02-23 |
| Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo (NCT03429595) | UNION therapeutics | 2018-02-23 |
| Clinical Efficacy Evaluation of Three Dentifrices (NCT03988374) | Church & Dwight Company, Inc. | 2018-02-22 |
| A Study of Duvelisib in Participants With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) (NCT03372057) | SecuraBio | 2018-02-22 |
| Autologous Stem Cell Transplant for Crohn's Disease (NCT03219359) | Aaron Etra | 2018-02-22 |
| Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM (NCT04195139) | University of Sydney | 2018-02-22 |
| mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA) (NCT03288350) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2018-02-22 |
| Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer (NCT03448458) | Emory University | 2018-02-22 |
| Prognostic Value of Lymph Node Dissection in Patients With Transitional Cell Carcinoma of the Upper Urinary Tract (NCT03474926) | RenJi Hospital | 2018-02-22 |
| Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Lovastatin in the Preservation of the Tooth Socket (NCT03981601) | Islamic Azad University, Sanandaj | 2018-02-22 |
| Maekmoondong-tang on Post-operative Cough in Patients With Lung Cancer (NCT03384667) | Seong-Gyu Ko | 2018-02-22 |
| Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment (NCT03525652) | The First Affiliated Hospital of Guangdong Pharmaceutical University | 2018-02-22 |
| Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder (NCT03430180) | Finnish Institute for Health and Welfare | 2018-02-22 |
| Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma (NCT03047928) | Inge Marie Svane | 2018-02-22 |
| Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant (NCT03380377) | Stanley Jordan, MD | 2018-02-21 |
| Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) (NCT03297398) | OPKO Health, Inc. | 2018-02-21 |
| An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) (NCT03339297) | Jazz Pharmaceuticals | 2018-02-21 |
| A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH) (NCT03177603) | GlaxoSmithKline | 2018-02-21 |
| Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma (NCT03475628) | Hellenic Society of Hematology | 2018-02-21 |
| Open Label, Study Of Efficacy and Safety Of AVR-RD-01 for Treatment-Naive Subjects With Classic Fabry Disease (NCT03454893) | AVROBIO | 2018-02-21 |
| Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye (NCT02697630) | Vastra Gotaland Region | 2018-02-21 |
| A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer (NCT03416244) | AIO-Studien-gGmbH | 2018-02-21 |
| Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma (NCT03201250) | University of Nebraska | 2018-02-21 |
| Nivolumab Combined With Daratumumab With or Without Low-dose Cyclophosphamide (NCT03184194) | Amsterdam UMC, location VUmc | 2018-02-21 |
| A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera (NCT03287245) | Hoffmann-La Roche | 2018-02-21 |
| Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS) (NCT03525418) | Longeveron Inc. | 2018-02-21 |
| Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (NCT03194867) | Sanofi | 2018-02-21 |
| IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome (NCT03175978) | IGF Oncology, LLC | 2018-02-21 |
| A Study of GLWL-01 in Patients With Prader-Willi Syndrome (NCT03274856) | GLWL Research Inc. | 2018-02-20 |
| A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula (NCT03174353) | University of Washington | 2018-02-20 |
| Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures (NCT03355300) | Radius Pharmaceuticals, Inc. | 2018-02-20 |
| Evaluating Low-dose Deferasirox (DFX) in Patients With Low-risk MDS Resistant or Relapsing After ESA Agents (NCT03387475) | University Hospital, Grenoble | 2018-02-20 |
| Intranasal Vasopressin Treatment in Children With Autism (NCT03204786) | Stanford University | 2018-02-20 |
| Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT (NCT03455972) | The First Affiliated Hospital of Soochow University | 2018-02-20 |
| Elotuzumab in Patients With Multiple Myeloma Before and After Peripheral Stem Cell Autologous Graft (NCT03393273) | Assistance Publique - Hôpitaux de Paris | 2018-02-20 |
| 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis (NCT03445884) | Rigshospitalet, Denmark | 2018-02-20 |
| Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4 (NCT03318315) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-02-20 |
| A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH) (NCT03311854) | Swedish Orphan Biovitrum | 2018-02-20 |
| Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices) (NCT07496918) | Massachusetts Institute of Technology | 2018-02-20 |
| Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT03437941) | Corcept Therapeutics | 2018-02-20 |
| Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas (NCT03198026) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2018-02-20 |
| An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread (NCT03414983) | Bristol-Myers Squibb | 2018-02-20 |
| VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults (NCT03327727) | Vical | 2018-02-20 |
| A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis (NCT03393013) | Kezar Life Sciences, Inc. | 2018-02-20 |
| Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer (NCT03412383) | Peking Union Medical College | 2018-02-20 |
| Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects (NCT03248570) | University of California, San Francisco | 2018-02-20 |
| Contact Lenses With New UV-blocker Manufactured With Different Techniques (NCT03475875) | Johnson & Johnson Vision Care, Inc. | 2018-02-19 |
| Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors (NCT03386721) | Hoffmann-La Roche | 2018-02-19 |
| Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer (NCT03384914) | H. Lee Moffitt Cancer Center and Research Institute | 2018-02-19 |
| A Treatment Extension Study of Mucopolysaccharidosis Type IIIB (NCT03784287) | Allievex Corporation | 2018-02-19 |
| Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer (NCT03161522) | M.D. Anderson Cancer Center | 2018-02-19 |
| Fentanyl Effect on Blood Pressure in Elderly Patients After Induction of General Anesthesia (NCT02489019) | Loyola University | 2018-02-19 |
| Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus (NCT03350035) | Marinus Pharmaceuticals | 2018-02-19 |
| Personalized Booster Feedback After Alcohol Health Education (NCT03440476) | Abby Braitman | 2018-02-19 |
| Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women (NCT03475706) | Velicept Therapeutics, Inc. | 2018-02-19 |
| Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer (NCT03101748) | M.D. Anderson Cancer Center | 2018-02-19 |
| 68Ga PSMA in Preprostatectomy Patients (NCT03388346) | Michael Graham PhD, MD | 2018-02-16 |
| Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME) (NCT03466099) | KalVista Pharmaceuticals, Ltd. | 2018-02-16 |
| A Long Term Safety Study of BCX7353 in Hereditary Angioedema (NCT03472040) | BioCryst Pharmaceuticals | 2018-02-16 |
| 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer (NCT03389451) | Michael Graham PhD, MD | 2018-02-16 |
| Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery (NCT03334409) | Academic and Community Cancer Research United | 2018-02-16 |
| Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment (NCT03450057) | Hellenic Society of Hematology | 2018-02-15 |
| Folinic Acid in Autism (NCT03771560) | University of California, San Francisco | 2018-02-15 |
| Ketamine in Borderline Personality Disorder (NCT03395314) | Yale University | 2018-02-15 |
| A Study of the Effect of 20 mg Ambroxol Hydrochloride on Acute Cough. (NCT03415269) | Hull University Teaching Hospitals NHS Trust | 2018-02-15 |
| Efficacy and Safety of TAK-653 in Treatment-Resistant Depression (NCT03312894) | Millennium Pharmaceuticals, Inc. | 2018-02-15 |
| Ipilimumab and Nivolumab in Leptomeningeal Metastases (NCT02939300) | Massachusetts General Hospital | 2018-02-15 |
| ADCC Mediated B-Cell dEpletion and BAFF-R Blockade (NCT03217422) | Novartis Pharmaceuticals | 2018-02-15 |
| Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas (NCT03255018) | National Cancer Institute (NCI) | 2018-02-15 |
| Pregabalin as Treatment for Alcohol Use Disorder (NCT03256253) | New York State Psychiatric Institute | 2018-02-15 |
| CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma (NCT03425279) | BioAtla, Inc. | 2018-02-15 |
| Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease (NCT03441061) | M.D. Anderson Cancer Center | 2018-02-15 |
| Efficacy of Block Injection of an Anti Inflammatory Medicine in Patients With Mandibular Dental Pain (NCT03410212) | Azad University of Medical Sciences | 2018-02-15 |
| Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel (NCT04110860) | Sara Botros | 2018-02-15 |
| Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel (NCT04110834) | Sara Botros | 2018-02-15 |
| Robotic Assisted Transanal Total Mesorectal Excision Surgery for Rectal Cancer in Low Site (NCT03422835) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2018-02-15 |